Tollenaar RAEM - Search Results

1

The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact.

van Pelt GW, Sandberg TP, Morreau H, Gelderblom H, van Krieken JHJM, Tollenaar RAEM, Mesker WE. van Pelt GW, et al. Among authors: tollenaar raem. Histopathology. 2018 Aug;73(2):197-206. doi: 10.1111/his.13489. Epub 2018 Mar 24. Histopathology. 2018. PMID: 29457843 Free article. Review.

2

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.

Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, Hermans J, van Dierendonck JH. Tollenaar RA, et al. Br J Cancer. 1998 Jun;77(11):1842-7. doi: 10.1038/bjc.1998.306. Br J Cancer. 1998. PMID: 9667656 Free PMC article.

3

Micrometastases and survival in stage II colorectal cancer.

Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, Tollenaar RA. Liefers GJ, et al. N Engl J Med. 1998 Jul 23;339(4):223-8. doi: 10.1056/NEJM199807233390403. N Engl J Med. 1998. PMID: 9673300 Free article.

4

Molecular detection of minimal residual disease in colorectal and breast cancer.

Liefers GJ, Tollenaar RA, Cleton-Jansen AM. Liefers GJ, et al. Histopathology. 1999 May;34(5):385-90. doi: 10.1046/j.1365-2559.1999.00716.x. Histopathology. 1999. PMID: 10231411 Review.

5

Caspase-3 activity as a prognostic factor in colorectal carcinoma.

Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ. Jonges LE, et al. Lab Invest. 2001 May;81(5):681-8. doi: 10.1038/labinvest.3780277. Lab Invest. 2001. PMID: 11351040 Free article.

6

Mechanisms of oncogenesis in colon versus rectal cancer.

Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH. Kapiteijn E, et al. J Pathol. 2001 Sep;195(2):171-8. doi: 10.1002/path.918. J Pathol. 2001. PMID: 11592095

7

Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.

Menon AG, Morreau H, Tollenaar RA, Alphenaar E, Van Puijenbroek M, Putter H, Janssen-Van Rhijn CM, Van De Velde CJ, Fleuren GJ, Kuppen PJ. Menon AG, et al. Lab Invest. 2002 Dec;82(12):1725-33. doi: 10.1097/01.lab.0000043124.75633.ed. Lab Invest. 2002. PMID: 12480922 Free article.

8

A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.

Menon AG, Fleuren GJ, Alphenaar EA, Jonges LE, Janssen van Rhijn CM, Ensink NG, Putter H, Tollenaar RA, van de Velde CJ, Kuppen PJ. Menon AG, et al. Cancer Immunol Immunother. 2003 Feb;52(2):121-6. doi: 10.1007/s00262-002-0363-6. Epub 2003 Jan 30. Cancer Immunol Immunother. 2003. PMID: 12594576 Free PMC article.

9

Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.

Menon AG, Kuppen PJ, van der Burg SH, Offringa R, Bonnet MC, Harinck BI, Tollenaar RA, Redeker A, Putter H, Moingeon P, Morreau H, Melief CJ, van de Velde CJ. Menon AG, et al. Cancer Gene Ther. 2003 Jul;10(7):509-17. doi: 10.1038/sj.cgt.7700600. Cancer Gene Ther. 2003. PMID: 12833131

10

Automated analysis of multiple sections for the detection of occult cells in lymph nodes.

Mesker WE, Doekhie FS, Vrolijk H, Keyzer R, Sloos WC, Morreau H, O'Kelly PS, de Bock GH, Tollenaar RA, Tanke HJ. Mesker WE, et al. Clin Cancer Res. 2003 Oct 15;9(13):4826-34. Clin Cancer Res. 2003. PMID: 14581354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page